Martin Tolar
Company: Alzheon
Job title: Founder, President & CEO
Seminars:
ALZ-801 Phase 3 Program: A Targeted Oral Disease Modifying Therapy for Alzheimer’s Disease 3:00 pm
day: Day One
Live Q&A With Your Expert Speakers 4:00 pm
day: Day One